In December 2018, the Department of Commerce National Institute of Standards (NIST) published NIST Special Publication 1234, “Return on Investment Initiative for Unleashing American Innovation” as a draft Green Paper.Tags: Penn EssayStrong Argumentative EssayBusiness Plan For Jewellery BusinessUsmle Personal Statement Internal MedicineHow To Write A Research Paper SampleCase Study In Six Sigma Methodology Manufacturing Quality Improvement And Guidance For Managers
In short, the system socializes risk and privatizes gain.
An innovation policy in the service of social goals was once a major goal of American progressives.
By using innovative weight-reducing materials and energy-saving processes, we reduce greenhouse gas (GHG) emissions, and by integrating different technologies we further advance preceding R&D on non-petrochemical materials.
In these and many other ways, we contribute to the solution of resource and energy problems as well as global environmental problems through green innovation.
Additionally, we suggest changes to the existing system that would increase public ownership and control over the economic gains generated by publicly-funded innovation programs.
Since World War II, the federal government’s R&D programs have been critical to the development of many of the economy’s most transformative technologies.R&D is oriented overwhelmingly toward military purposes, and the direct gains from innovation tend to concentrate in particular geographic areas, many of which are already thriving.Most importantly, the current system is built on an unfair arrangement for the public: innovation programs tend to channel public investments into private hands for commercialization without direct public reimbursement.During and immediately after WWII, lawmakers from the progressive wing of the Democratic Party proposed to extend public R&D programs in keeping with New Deal policy aims.They understood technology programs as a new form of social policy, and proposed that the government should direct innovation to serve broad social goals and regional development.concentration, water shortages due to increasing population, and resource depletion – are growing ever more serious.Against that backdrop, Toray has stated its commitment to management focused on the global environment, and we are strongly promoting projects to expand our green innovation business.Some of the proposals are promising, but others are designed to neuter safeguards in the Bayh-Dole Act, and in particular, to protect companies that sell expensive drugs, vaccines, diagnostic tests and gene- and cell-treatments like CAR T from obligations to ensure products are affordable and accessible.The initiative was launched after an April 19, 2018 “Unleashing American Innovation Symposium” in Washington, DC,” and followed four public hearings and a request for comments noticed on May 1, 2018 (83 FR 19052). What started out as a review of licensing practices by federal labs ended upon with an attack on reasonable pricing obligations for drugs and other inventions.The draft green paper is 135 pages long, with 313 footnotes, and 8 pages of references.On page 7, there is a Summary of Intended Actions which is divided into 5 strategies.